Please login to the form below

Not currently logged in
Email:
Password:

Therachon

This page shows the latest Therachon news and features for those working in and with pharma, biotech and healthcare.

Pfizer buys dwarfism drug company Therachon for $810m

Pfizer buys dwarfism drug company Therachon for $810m

Will rival BioMarin pipeline drug. Pfizer is spending $340m to acquire Therachon, a European biotech with a drug in trials for achondroplasia, a form of short-limbed dwarfism. ... By acquiring Therachon, we hope to leverage Pfizer’s leading scientific

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Therachon poaches Shire’s Aled Williams Therachon poaches Shire’s Aled Williams

    Therachon, a clinical-stage biotechnology company, has appointed Aled Williams to the position of chief commercial officer and head of patient access. ... in developing TA-46, and advancing Therachon’s pipeline of drug candidates that aim to bring a

  • Therachon appoints Christian Meyer as chief medical officer Therachon appoints Christian Meyer as chief medical officer

    He succeeds Maarten Kraan who remains as an advisor. Therachon has appointed Christian Meyer as its new chief medical officer, a role that will see him succeed Maarten Kraan, who will ... Luca Santarelli, chief executive officer and director, Therachon,

  • Therachon appoints new chief medical officer Therachon appoints new chief medical officer

    him focus on the clinical development of TA-46 - Therachon’s leading drug in development for achondroplasia. ... Luca Santarelli, chief medical officer at Therachon, said: “Dr Kraan’s wealth of translational and drug development expertise is

  • Therachon strengthens management team Therachon strengthens management team

    MacroGenics. Meanwhile, Dr Schikan (pictured below right) joins Therachon's board as a non-executive director. ... Dr Luca Santarelli, Therachon's chief executive officer and director, said: “I am delighted to have Drs Schikan, Porter and Stavenhagen

More from appointments
Approximately 4 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics